Suppr超能文献

骨内注射腺苷。与外周或中心静脉给药效果相同吗?

Intraosseous adenosine. As effective as peripheral or central venous administration?

作者信息

Getschman S J, Dietrich A M, Franklin W H, Allen H D

机构信息

Division of Clinical Pharmacology/Toxicology, Ohio State University, Children's Hospital, Columbus.

出版信息

Arch Pediatr Adolesc Med. 1994 Jun;148(6):616-9. doi: 10.1001/archpedi.1994.02170060070014.

Abstract

OBJECTIVE

The purpose of this study was to determine if intraosseous administration of adenosine is effective and, if so, to establish therapeutic dosage criteria for the intraosseous route compared with peripheral or central intraosseous route compared with peripheral or central venous routes.

RESEARCH DESIGN

Randomized, unblinded, cross-over, within-animal control study.

SETTING

University hospital in Ohio.

SUBJECTS

Thirty newly weaned piglets.

SELECTION PROCEDURE

Consecutive sample.

INTERVENTIONS

Thirty newly weaned pigs were transesophageally (n = 26) or transvenously (n = 4) paced at a cycle length that was 10% longer than the Wenckebach threshold. The minimum effective dose of adenosine necessary to induce atrioventricular block during pacing was recorded for peripheral venous, central venous, and intraosseous routes.

MEASUREMENTS AND RESULTS

The baseline resting heart rate and Wenckebach thresholds were not statistically different between subjects or between different routes of administration. The intraosseous route required a minimum effective dose of 127 micrograms/kg. Using a log transformation, the difference between central venous and peripheral venous doses was found to be statistically significant. The intraosseous dose was not statistically different from the central venous or peripheral venous doses.

CONCLUSION

The intraosseous route is an effective way of administering adenosine. The peripheral venous dose required to achieve atrioventricular block is higher than the central venous dose and the intraosseous dose is intermediary to the central venous and peripheral venous doses.

摘要

目的

本研究旨在确定骨内给予腺苷是否有效,若有效,则与外周或中心静脉途径相比,确立骨内途径的治疗剂量标准。

研究设计

随机、非盲、交叉、动物自身对照研究。

研究地点

俄亥俄州的大学医院。

研究对象

30只刚断奶的仔猪。

选择程序

连续抽样。

干预措施

30只刚断奶的猪经食管(n = 26)或经静脉(n = 4)以比文氏阻滞阈值长10%的周期长度进行起搏。记录起搏期间诱导房室传导阻滞所需的腺苷最低有效剂量,包括外周静脉、中心静脉和骨内途径。

测量与结果

受试者之间或不同给药途径之间的基线静息心率和文氏阻滞阈值无统计学差异。骨内途径所需的最低有效剂量为127微克/千克。经对数转换后,发现中心静脉剂量与外周静脉剂量之间的差异具有统计学意义。骨内剂量与中心静脉或外周静脉剂量无统计学差异。

结论

骨内途径是给予腺苷的有效方式。实现房室传导阻滞所需的外周静脉剂量高于中心静脉剂量,而骨内剂量介于中心静脉和外周静脉剂量之间。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验